NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3955421 Query DataSets for GSM3955421
Status Public on Jul 19, 2020
Title Patient X9 14 weeks after starting Omalizumab Treatment
Sample type RNA
 
Source name Whole blood
Organism Homo sapiens
Characteristics tissue: Whole blood
diagnosis: asthma
Sex: Female
age: 45
omalizumab responder status: Non-responder
Extracted molecule total RNA
Extraction protocol Total RNA was isolated utilizing MagMax Nucleic Acid Isolation kit (Ambion) according to manufacturer's protocol. Globin mRNA was removed with using Globin Clear kit (Ambion).
Label biotin
Label protocol 1500ng of RNA from each sample that passed quality control was amplified and labled using Illumina TotalPrep RNA Amplification kit following manufacturer's protocol
 
Hybridization protocol Amplified and labeled RNA was hybridized overnight to beadchips following standard Illumina protocol
Scan protocol Scanned on Illumina HiScan following standard Illumina protocol
Description raw data file:
Non-normalized_data_2.txt
X9W14
ACT Score 15, FEV1 73
Data processing Each sample was background subtracted and scaled to the average of all samples. Raw values less than 10 were set to 10 and the data was log2 transformed. Probes were then filtered to select transcripts that were present in at least one sample (PALO) using an alpha of 0.01 for the signal detection, thus eliminating background. The probes were then additionally filtered by removing probes with the lowest variability using a standard deviation of less than 0.344.
 
Submission date Jul 19, 2019
Last update date Jul 19, 2020
Contact name Sangkon Oh
Organization name Mayo Clinic
Department immunology
Lab oh lab
Street address 13400 east Shea street
City Scottsdale
State/province AZ
ZIP/Postal code 85259
Country USA
 
Platform ID GPL10558
Series (1)
GSE134544 Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab

Data table header descriptions
ID_REF
VALUE Average signal

Data table
ID_REF VALUE
ILMN_2055271 5.113682165
ILMN_3241953 5.823585061
ILMN_1745607 3.32
ILMN_2295559 3.32
ILMN_1735045 3.32
ILMN_1680754 3.799270741
ILMN_1659452 3.32
ILMN_1755321 4.698257379
ILMN_1698554 4.843057248
ILMN_1814092 5.545557612
ILMN_2061446 7.397578807
ILMN_1676336 6.266813333
ILMN_1668851 3.32
ILMN_2270015 3.572301559
ILMN_3237396 7.04591143
ILMN_1688755 8.09343658
ILMN_1653165 6.657764321
ILMN_1662364 10.05804586
ILMN_1674698 7.499407433
ILMN_1700461 7.377034359

Total number of rows: 28402

Table truncated, full table size 652 Kbytes.




Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap